There is still no cure for type 1 diabetes, despite decades of research and promises. Most people with the disease say that a “cure” should mean being able to live a healthy life, free of dependence on external insulin—and without using powerful drugs that suppress the body's immune response. Only one current line of research holds real hope for both in the near term: the therapy known as encapsulated islets or the bioartificial pancreas. Hanuman Medical Foundation supports this vital research through its work with the Islet Sheet Project, a long-term collaboration by a team of leading diabetes researchers and medical inventors.
The Islet Sheet Project expects to begin clinical trials in 2013. This can be life-changing news for people with type 1 diabetes and their loved ones. We're committed to real progress, not promises. Please read on … and join us.
“We believe this technology has significant potential to be considered a ‘cure’ for type 1 diabetes.”
—The authors of Targeting a Cure for Type 1 Diabetes
NEWS
Hanuman Medical Foundation Talks to Richard Bergman
March 9, 2012
Hanuman Medical Foundation recently interviewed Dr. Richard N. Bergman, PhD, about the new Cedars-Sinai Diabetes and Obesity Research Institute he directs, and about his distinguished career as a... READ MORE
Large-Animal Trials of Islet Sheet Begin
January 17, 2012
Today the definitive large-animal study of the Islet Sheet encapsulation device kicked off with the first surgical procedure under the approved protocol. This was a practice pancreatectomy on a... READ MORE
This blog is most often authored by Scott R. King, president and founder of Islet Sheet Medical, a biotechnology company working with Hanuman Medical Foundation. Scott was diagnosed with type 1 diabetes in 1977, and since then has been devoted to understanding and ameliorating the disease. The Sheet shares updates on our work and welcomes comments.
The Other Diabetes
May 14th, 2012
Like other mainstream media, the Wall Street Journal rarely notices type 1 diabetes (or, as I have suggested, “autoimmune diabetes”). But in a recent article on prevention of autoimmune diabetes, the Journal floated a new name for “our” diabetes: it is now the other diabetes. The distinction between type 1 and type 2 diabetes goes back... READ MORE
Glucose Meters Conquer the World
April 30th, 2012
The personal glucose meter is the most important advance in diabetes care in my thirty-five years of living with type 1. What if this humble machine is the killer app that will reform health care? Personal electronic devices are transforming commerce through disintermediation, meaning that the internet and high-speed computing give you direct access to... READ MORE
Animated views of how the Islet Sheet with its encapsulated islets works
